NCT04895592: Radiosurgery Before Surgery for the Treatment of Brain Metastases

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Early Phase 1
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Brain metastases must be visible on contrasted magnetic resonance imaging (MRI) of the brain
Exclusions: Patients with prior whole brain radiotherapy or SRS to the same site planned for surgery

Comments are closed.

Up ↑